Booster adds $4.14M to NZ university spin-out fund
What's the deal? Booster has committed a further US$4.79M to its Booster Innovation Fund, which backs early-stage New Zealand companies built on university research and technology. The allocation lifts total capital committed from Booster-managed funds to more than US$14.9M.
By the numbers: The NZX-listed fund has invested US$10.4M so far and holds stakes in more than 40 active companies. Those businesses carry a combined enterprise value of more than US$582.4M and employ over 300 people.
What's the endgame? Booster sources deals through partnerships with commercialisation offices at Victoria University of Wellington, the University of Otago, and the University of Auckland, giving it early sight of research with commercial potential. Around 30 portfolio companies originate from publicly funded research.
Chief executive officer Diana Papadopoulos said New Zealand's universities "produce research with the potential to solve significant global problems," adding that spin-outs offer "differentiated technology, stronger intellectual property moats and the ambition to compete in global markets."
Where the money goes: The portfolio spans cancer treatment, health diagnostics, electrification, minerals recovery, decarbonisation, agriculture, and machine learning. Named companies include Alimetry, Ferronova, Mars Bioimaging, Allegro Energy, and BioLumic.
Who's exposed? A small allocation to the fund already sits inside Booster products such as KiwiSaver and managed funds, so many retail savers hold indirect exposure. Individuals can also invest directly for as little as $500.
The signal: Venture funding tied to university commercialisation is a small but growing part of New Zealand's capital market. Booster argues its formal links to technology transfer offices set it apart from other local investors — a bet that science-led ventures need specialist backers willing to come in early.
Read more: itbrief.co.nz
Image credit: NASA Goddard Photo and Video
